The latest price target for Medicine Man Technologies (OTCEM:SHWZ) was reported by Benchmark on August 14, 2024. The analyst firm set a price target for $2.50 expecting SHWZ to rise to within 12 months (a possible 2172.73% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Medicine Man Technologies (OTCEM:SHWZ) was provided by Benchmark, and Medicine Man Technologies reiterated their buy rating.

There is no last upgrade for Medicine Man Technologies

There is no last downgrade for Medicine Man Technologies.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicine Man Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicine Man Technologies was filed on August 14, 2024 so you should expect the next rating to be made available sometime around August 14, 2025.

While ratings are subjective and will change, the latest Medicine Man Technologies (SHWZ) rating was a reiterated with a price target of $2.50 to $2.50. The current price Medicine Man Technologies (SHWZ) is trading at is $0.11, which is out of the analyst’s predicted range.